Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event By: ACCESSWIRE November 13, 2024 at 04:30 AM EST EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation. Event: Q4 Investor SummitDate: Thursday, November 21, 2024Presentation Time: 1:30pm - 2:00pm ETLocation: https://www.webcaster4.com/Webcast/Page/3075/51590 The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. About NeuroOneNeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com. Contact:Fred Rockwellfred@investorsummitgroup.comInvestor Summit Group NMTC IR ContactQuinn Callanan, CFA or Brian Prenoveau, CFAMZ Group - MZ North AmericaNMTC@mzgroup.us(949) 694-9594 SOURCE: NeuroOne Medical Technologies Corporation View the original press release on accesswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event By: ACCESSWIRE November 13, 2024 at 04:30 AM EST EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation. Event: Q4 Investor SummitDate: Thursday, November 21, 2024Presentation Time: 1:30pm - 2:00pm ETLocation: https://www.webcaster4.com/Webcast/Page/3075/51590 The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. About NeuroOneNeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com. Contact:Fred Rockwellfred@investorsummitgroup.comInvestor Summit Group NMTC IR ContactQuinn Callanan, CFA or Brian Prenoveau, CFAMZ Group - MZ North AmericaNMTC@mzgroup.us(949) 694-9594 SOURCE: NeuroOne Medical Technologies Corporation View the original press release on accesswire.com
EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation. Event: Q4 Investor SummitDate: Thursday, November 21, 2024Presentation Time: 1:30pm - 2:00pm ETLocation: https://www.webcaster4.com/Webcast/Page/3075/51590 The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. About NeuroOneNeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com. Contact:Fred Rockwellfred@investorsummitgroup.comInvestor Summit Group NMTC IR ContactQuinn Callanan, CFA or Brian Prenoveau, CFAMZ Group - MZ North AmericaNMTC@mzgroup.us(949) 694-9594 SOURCE: NeuroOne Medical Technologies Corporation View the original press release on accesswire.com
